(Q24653814)
Statements
Safety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coli (English)
0 references
January 2010
0 references
54
0 references
1
0 references
239-43
0 references
1 reference
1 reference
1 reference